Discover our medicines
Our innovative medicines address society’s greatest disease burdens and restore possibility for patients.
Explore our science
Discover how we unravel the mysteries of biology and develop new technologies to fight disease and change lives.
Learn about our impact
Creating a medicine is just the beginning of the journey. Discover how we embrace societal impact as a core business objective.
ASCO Annual Meeting 2025
Pride 2025 | CommUNITY belongs here
This Pride Month, we’re shining a light on the power of belonging. When you're surrounded by people who lift you up, challenge you to grow, and celebrate who you are there’s no limit to what we can reimagine. Together.
Latest news
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
Novartis announces commencement of tender offer to acquire Regulus Therapeutics
Live. Magazine
Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.
Novartis in Society Integrated Report 2024
Read more about our performance against our business, environmental, social and governance (ESG) priorities in the Novartis in Society Integrated Report 2024.